Rice Hall James & Associates’s Zimmer Biomet ZBH Stock Holding History

Rice Hall James & Associates’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Sell	2,737 -926	-25%	-$81.2K	0.01%	236
2026 Q1	$331K	Buy	3,663 +76	+2%	+$6.97K	0.02%	231
2025 Q4	$323K	Sell	3,587 -863	-19%	-$81.8K	0.02%	231
2025 Q3	$438K	Sell	4,450 -11	-0.2%	-$1.09K	0.02%	230
2025 Q2	$407K	Sell	4,461 -382	-8%	-$36.9K	0.02%	228
2025 Q1	$548K	Buy	4,843 +23	+0.5%	+$2.46K	0.03%	217
2024 Q4	$509K	Sell	4,820 -14	-0.3%	-$1.5K	0.03%	227
2024 Q3	$522K	Sell	4,834 -113	-2%	-$12.3K	0.03%	228
2024 Q2	$537K	Sell	4,947 -40	-0.8%	-$4.71K	0.03%	227
2024 Q1	$658K	Sell	4,987 -4,172	-46%	-$521K	0.04%	221
2023 Q4	$1.11M	Hold	9,159	–	–	0.06%	210
2023 Q3	$1.03M	Hold	9,159	–	–	0.07%	203
2023 Q2	$1.33M	Sell	9,159 -6,020	-40%	-$818K	0.08%	198
2023 Q1	$1.96M	Sell	15,179 -218	-1%	-$27.4K	0.11%	186
2022 Q4	$1.96M	Sell	15,397 -485	-3%	-$56.3K	0.11%	189
2022 Q3	$1.66M	Sell	15,882 -173	-1%	-$19K	0.1%	205
2022 Q2	$1.69M	Sell	16,055 -211	-1%	-$25K	0.08%	205
2022 Q1	$2.08M	Sell	16,266 -658	-4%	-$79.3K	0.08%	209
2021 Q4	$2.09M	Hold	16,924	–	–	0.07%	210
2021 Q3	$2.4M	Sell	16,924 -289	-2%	-$42.5K	0.09%	177
2021 Q2	$2.69M	Sell	17,213 -35	-0.2%	-$5.67K	0.1%	166
2021 Q1	$2.68M	Sell	17,248 -853	-5%	-$132K	0.09%	160
2020 Q4	$2.71M	Sell	18,101 -4,836	-21%	-$683K	0.1%	151
2020 Q3	$3.03M	Sell	22,937 -840	-4%	-$110K	0.12%	125
2020 Q2	$2.75M	Sell	23,777 -553	-2%	-$63.7K	0.12%	130
2020 Q1	$2.39M	Sell	24,330 -321	-1%	-$42.1K	0.13%	129
2019 Q4	$3.58M	Buy	24,651 +38	+0.2%	+$5.25K	0.12%	127
2019 Q3	$3.28M	Sell	24,613 -46	-0.2%	-$5.94K	0.12%	126
2019 Q2	$2.82M	Buy	24,659 +1,306	+6%	+$153K	0.09%	147
2019 Q1	$2.9M	Sell	23,353 -712	-3%	-$80.9K	0.09%	144
2018 Q4	$2.42M	Sell	24,065 -319	-1%	-$35.9K	0.09%	146
2018 Q3	$3.11M	Sell	24,384 -115	-0.5%	-$13.7K	0.11%	134
2018 Q2	$2.65M	Buy	24,499 +17,344	+242%	+$1.89M	0.1%	149
2018 Q1	$758K	Hold	7,155	–	–	0.03%	252
2017 Q4	$838K	Sell	7,155 -103	-1%	-$11.6K	0.03%	261
2017 Q3	$825K	Hold	7,258	–	–	0.04%	248
2017 Q2	$905K	Hold	7,258	–	–	0.04%	246
2017 Q1	$861K	Hold	7,258	–	–	0.04%	253
2016 Q4	$727K	Sell	7,258 -1	-0%	-$107	0.04%	253
2016 Q3	$916K	Hold	7,259	–	–	0.05%	245
2016 Q2	$848K	Hold	7,259	–	–	0.05%	248
2016 Q1	$751K	Hold	7,259	–	–	0.04%	244
2015 Q4	$723K	Hold	7,259	–	–	0.04%	248
2015 Q3	$662K	Hold	7,259	–	–	0.04%	252
2015 Q2	$770K	Hold	7,259	–	–	0.04%	254
2015 Q1	$828K	Hold	7,259	–	–	0.05%	256
2014 Q4	$799K	Hold	7,259	–	–	0.05%	250
2014 Q3	$709K	Sell	7,259 -41	-0.6%	-$4.03K	0.05%	245
2014 Q2	$736K	Hold	7,300	–	–	0.05%	247
2014 Q1	$670K	Buy	7,300 +1	+0%	+$92	0.05%	247
2013 Q4	$660K	Buy	7,299 +104	+1%	+$9K	0.05%	243
2013 Q3	$574K	Hold	7,195	–	–	0.06%	216
2013 Q2	$523K	Buy	+7,195	New	+$538K	0.05%	221

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rice Hall James & Associates's ZBH Position: Q2 2026 in Review

Rice Hall James & Associates reduced its Zimmer Biomet (ZBH) stake by 25% in Q2 2026, selling an estimated $81.2K and leaving 2,737 shares worth $236K. The position accounts for 0.01% of the portfolio, ranked #236.

Rice Hall James & Associates first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.58M in Q4 2019. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Rice Hall James & Associates held 2,737 shares of Zimmer Biomet worth $236K as of Q2 2026.
Rice Hall James & Associates sold 926 Zimmer Biomet shares in Q2 2026, an estimated $81.2K.
Zimmer Biomet made up 0.01% of Rice Hall James & Associates's portfolio in Q2 2026, its #236 holding.
Rice Hall James & Associates first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
Rice Hall James & Associates's Zimmer Biomet position peaked at $3.58M in Q4 2019.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.